Call for applications for JCI Editor, 2027-2032

The American Society for Clinical Investigation (ASCI) invites applications for the position of Editor in Chief of the Journal of Clinical Investigation (JCI). The JCI, one of the oldest and most respected biomedical journals, is renowned for publishing exemplary studies focused on the mechanistic basis and treatment of disease. The ASCI seeks a dynamic Editor in Chief who will lead a team of academic editors to invigorate the Journal in the highly competitive publishing landscape.

Duties of the Editor

The Editor is responsible for determining the scientific scope and content of the JCI; ensuring the quality and integrity of publications; assembling and leading an editorial board to handle research submissions; and meeting goals set by the ASCI Council and Publications Committee. The selected candidate’s responsibilities include service on the ASCI Council. The term of office is 5 years and begins March 2027.

Strategic Focus

The Editor in Chief must provide a clear vision for the future scientific development of the JCI, with a particular emphasis on how the Journal can expand its portfolio of high-impact research publications, such as clinical trials, public health studies, translational studies, and cutting-edge genomics and bioinformatics research. The successful applicant should also articulate a vision for attracting high-quality submissions to the Journal from across the globe. It is also important to ensure that JCI complements rather than competes with JCI Insight in the ASCI Family of Journals. The Editor in Chief works in collaboration with the Editorial Board, the JCI Executive Editor, the ASCI publishing staff, and the ASCI Publications Committee to set priorities for the Journal.

Eligibility of the Editor and Editorial Board

To be considered for the position of Editor, a candidate must:

  • be a member of the ASCI and
  • demonstrate a strong scientific record.

For the proposed Editorial Board

  • At least 50% must be ASCI members (Active or Senior) in good standing.
  • Multi-institution applications are encouraged.

Application timeline

  • April 10, 2026: Letters of intent (LOI) due. Applicants submitting a LOI will receive an operational overview of the ASCI and JCI for use in developing full applications. The LOI only needs to identify the proposed Editor in Chief and their affiliated institution but does not need to include specific details regarding the application.
  • June 3, 2026: Full applications due.
  • July 2026: Finalists for the Editor position determined.
  • August 2026: Editor Selection Committee interviews finalists (date and location to be determined).

Full application requirements

The applicant should address the following areas in 5 or fewer single-spaced pages:

  • Describe your vision for the scientific scope of manuscripts published in the Journal under your leadership, including scientific areas you see as priorities for the JCI, potential new article categories (if applicable), and areas you see as opportunities for growth and increased impact.
  • Provide details regarding proposed editorial board members.
    • Describe how you will ensure that the team has the breadth to handle submissions across all specialties. including any areas of new or expanded emphasis for the Journal.
    • Describe how Clinical Research and Public Health submissions will be encouraged and handled and any board members with specific expertise in clinical research and translational medicine.
    • Specify board members with expertise in genomics and bioinformatics and how efforts will be made to encourage submissions in these areas.
  • Describe how the proposed board will evaluate manuscripts and specific efforts to ensure scientific rigor, fair decisions, and timeliness.
  • Describe your vision for attracting the best research submissions to the Journal. Consider the changing demographics of submitting authors, in terms of the growing volume of international submissions and potential volatility in US-based submissions.
  • Describe how you envision collaborating with the Editor in Chief of JCI Insight to ensure seamless handling of Dual-Journal Submissions and potential transfers from the JCI to JCI Insight.
  • Describe how you see the JCI’s mission with respect to serving the ASCI and its membership.
  • In the event that you cannot complete the duration of the term, describe the process by which a candidate to replace the Editor in Chief would be determined (subject to approval by the Council and a vote by the membership).

In addition, the application must include a letter from each proposed Board member stating a commitment to the role.

Submitting letters of intent and applications

Address materials to Julie A. Bastarache, MD, Chair of the Editor Selection Committee, and send as an attachment to staff@the-asci.org.

Questions

Contact Sarah Jackson, Executive Editor, at sarah.jackson@the-jci.org.

Review of applications

The Editor Selection Committee will review applications, interview candidates, and recommend a selection to the ASCI Council, which will then submit the recommendation to a vote of the Active segment of the ASCI membership.

Nominations open for 2026 Honorary membership

The ASCI is pleased to call for nominations for 2026 Honorary membership. Nominees for this recognition must fit the criteria as given in the ASCI bylaws:

Any distinguished person who has contributed significantly to the Society’s objectives, who has not been previously and unsuccessfully nominated for Active or International membership, and who enjoys an unimpeachable moral standing is eligible for nomination in this category.

For the nominee who meets these criteria, there is no restriction on age or degree held.

The deadline for receipt of nominations is January 6, 2026, at 11:59 pm Eastern. Nominations will be screened to ensure they are complete and fit the nomination criteria. The Council reviews nominations and submits its recommendations to Active and Senior members for approval.

The nominator must be an ASCI member in good standing and must start the nomination:

  • Access your member account
  • Go to the “Nominations” tab, then to the “Honorary membership nomination” section
  • Select “I’m the nominator” option
  • Search for your nominee:
    • If found, click on “Start nomination”
    • If no result is found, provide and save the requested information (first name, last name, and email address), then click on “Start nomination” for the newly created nominee in the “Results” section
  • At the top of the nomination form, click on “Send access notification to the nominee at: <email>”
  • Provide a 250-word limit statement on the nominee’s qualifications
  • Submit the statement, which can be done regardless of whether the nominee’s part of the nomination is completed

The nominee receives an email with information to access their part of the nomination and then must:

  • Provide a birth date and address information
  • Provide a brief (300-word limit) biography
  • Provide current institutional affiliation
  • Upload a full curriculum vitae and headshot photograph
  • Complete a demographics survey
  • Identify research domain(s)
  • Submit this aspect of the nomination, which can be done regardless of whether the nominator has completed her/his statement

Nominations for ASCI Council, 2026

The Society seeks nominations for the following ASCI Council vacancies arising in 2026 (all terms begin and end in the spring):

  • Vice President (4-year term, 2026-2030)
  • Secretary-Treasurer Elect (3-year term, 2026-2029)
  • Councilor (2 positions, 3-year term, 2026-2029)

Those eligible for nomination must be in the Active category and:

  • for Vice President, will not turn age 56 until 2031 or later
  • for Secretary-Treasurer Elect and Councilor, will not turn age 56 until 2030 or later

The Society strongly encourages members to consider diversity in identifying those suitable for nomination. Self-nominations are not permitted. Nominations may be submitted by any member in good standing (with dues up to date if applicable) and must be submitted by January 20, 2026, at 11:59 PM EST.

All Council members are expected to support the activities of and attend the ASCI annual meeting, and to participate in the general governance of the Society, including two in-person meetings (fall and spring, with the spring meeting occurring as part of the annual meeting) and videoconference calls (typically every other month). All Council members participate in the review of membership and various award nominations and subsequent discussion at the fall meeting.

The Vice President transitions to President-Elect in year 2, President in year 3, and Immediate Past President in year 4. This role is represented on numerous committees throughout the term of office. For the 2nd through 4th years of this position, this member is expected to participate significantly in matters related to the annual meeting. In the Presidential year (year 3), the member convenes a face-to-face Council meeting and oversees related review processes for nominations, notably including those to membership. The President works closely with the Association of American Physicians to create the annual meeting program and presents the traditional Presidential Address at the meeting.

The Council is supported by an Executive Director, Managing Director, and other staff members who oversee the day-to-day operations of the Society and effect initiatives as directed by the Council. For details on Officers and Councilors, see the ASCI Bylaws.

Nominators:

  • may be any ASCI member
  • must provide a statement (250-word limit) regarding the nominee

Nominees:

  • must specify the position of interest (Vice President, Secretary-Treasurer Elect, Councilor);
  • provide a 250-word candidate statement, written in first person, for consideration by the Council and for use as the ballot statement if the nominee is selected as a candidate (nominees may refer to candidate statements for the 2025 nomination cycle for guidance in drafting their own statements);
  • provide an NIH-style biosketch;
  • must complete the ASCI’s demographic survey and provide information about research domain(s)

To start a nomination:

  • Access your member account
  • Go to the “Nominations” tab
  • In the section for “Council vacancies”:
    • If you are the nominee, select the “I’m the nominee” option to start your part of the nomination (only you have access to this information).
    • If you are the nominator, select “I’m the nominator” option, then search for your nominee. Only nominees who are within the age-eligibility criteria will be returned in the results.

Nominations open for mid-career member awards, 2026

The ASCI is pleased to call for nominations for awards recognizing the scholarly achievements of mid-career members:

The Marian W. Ropes, MD, Award recognizes a middle-career woman physician-scientist. The annual award honors Dr. Ropes (1903–1994), a pioneer both as a researcher on the role of synovial fluid in joint diseases and as a woman in academic medicine. She was the first woman documented to have been elected to the ASCI. The recipient of this award will receive a $10,000 honorarium, be recognized at the ASCI’s 2026 annual meeting, and give the Ropes Lecture at the 2027 meeting.

The Louis W. Sullivan, MD, Award recognizes a middle-career physician-scientist from a population underrepresented in medicine and science. The award honors Dr. Sullivan (born 1933), a hematologist, health care advocate, and policy leader — having served as US Secretary of Health and Human Services — and who was the first Black physician-scientist elected to the ASCI. The recipient of this award will receive a $10,000 honorarium, be recognized at the ASCI’s 2026 annual meeting, and give the Sullivan Lecture at the 2027 meeting.

ASCI members who were elected in 2021 or more recently may be nominated. Additionally:

  • For the Ropes Award, only female members are eligible for nomination.
  • For the Sullivan Award, only UiMS members are eligible for nomination.

The deadline for receipt of nominations is December 12, 2025, at 11:59 pm Eastern. Nominations will be screened to ensure they are complete and fit the award criteria. The ASCI’s Physician-Scientist Engagement Committee reviews nominations and submit recommendations to the ASCI Council for approval. We expect to notify nominees about the outcome in January 2026.

Nominators:

  • must be ASCI members; current members of the ASCI Physician-Scientist Engagement Committee are excluded; and
  • must provide a statement regarding the nominee (500-word limit).

Nominees:

  • must fit the criteria noted above and may not be current members of the ASCI Council and/or Physician-Scientist Engagement Committee;
  • may be nominated for only one ASCI award (for example, a nominee for the Ropes Award may not be nominated for the Sullivan Award, Korsmeyer Award, Harrington Prize, or Scharschmidt~Crawford Award);
  • must provide the following:
    • a personal statement (750-word limit) on their scientific achievements, with attention to relevant personal and career history, mentoring experience, and service to the community;
    • a full curriculum vitae; and
    • 3 most-significant publications, each with a 50-word annotation, followed by the member’s role in the publication, the journal name and publication year, and the Pubmed ID noted as “PMID:12345”;
  • must complete the ASCI’s demographics survey; and
  • must provide information regarding their research domain(s).

To start a nomination:

  • Access your member account
  • Go to the “Nominations” tab
  • In the section for the award of interest:
    • If you are the nominee, select the “I’m the nominee” option to start your part of the nomination (only you have access to this information); note that in the case of the Ropes Award, this option will not be available for male members.
    • If you are the nominator, select “I’m the nominator” option, then search for your nominee. Only nominees who were elected starting 2020 will appear in the results. Note: for the Ropes Award, you will only be able to select a nominee who is a woman; for the Sullivan Award, you may select anyone who is within the election-year window, but nominations will be screened (based on the information the nominee provides in the demographics survey) to ensure they fit the UiMS criterion.

Definition of UiMS

The ASCI defines underrepresented in medicine in science as follows: Underrepresented in medicine and science (UiMS) refers to populations that are underrepresented relative to their numbers in the general US population. This includes, but is not necessarily limited to, physician-scientists who identify in the following racial and/or ethnic groups: Black/African American, Hispanic or Latin American, Native American/American Indian or Alaska Native, and Native Hawaiian and other Pacific Islander; individuals with disabilities: physical or mental impairment that substantially limits one or more major life activities; and those with an educationally or financially disadvantaged background.

Nominations open for the 2026 Seldin~Smith Award for Pioneering Research

The ASCI is pleased to call for nominations for the 2026 Seldin~Smith Award for Pioneering Research. The annual award, accompanied by an unrestricted $30,000 grant to advance academic efforts, honors an early-career physician-scientist who has demonstrated exceptional creativity and accomplishments in biomedical research (see past recipients).

The deadline for receipt of nominations is December 12, at 11:59 pm Eastern.

The nominee:

  • must be an MD (or the equivalent);
  • must be more than 2 years but not more than 6 years from first faculty (or the equivalent) appointment as of April 2026; and
  • spends substantial time in research while providing direct patient care.

A nomination must be started by the nominator, who then notifies the nominee to complete her/his part of the nomination. The nominee identifies the supporter of the nomination and notifies that person through the submission site to complete her/his support form. Note: The nominee may not be a past recipient of the Foundation for the NIH’s Trailblazer Prize for Clinician-Scientists.

Nominations will be screened to ensure they are complete and fit the nomination criteria. The Seldin~Smith Award Selection Committee reviews nominations and provides recommendations to the Seldin~Smith Award Advisory Committee to determine the recipient.

The nominator must be an ASCI member in good standing and must start the nomination:

  • Access your member account
  • Go to the “Nominations” tab, then to the “ASCI / Seldin~Smith Award for Pioneering Research” section
  • Select “I’m the nominator” option
  • Search for your nominee:
    • If found, click on “Create nomination”
    • If no result is found, provide and save the requested information (first name, last name, and email address), then click on “Create nomination” for the newly created nominee in the “Results” section
  • At the top of the nomination form, click on “Send access notification to the nominee at: <email>”
  • Provide a 500-word limit statement on the nominee’s most significant achievement
  • Submit the statement, which can be done regardless of whether the nominee’s part of the nomination is completed

The nominee receives an email with information to access her/his part of the nomination and then must:

  • Provide a birth date and address information
  • Provide a summary (100-word limit) of her/his research, followed by a notation of the percentage of time devoted to direct patient care
  • Provide detail of:
    • Degrees obtained
      • Year of first faculty or equivalent appointment
    • Current institutional affiliation
  • Upload:
    • Current NIH-style biosketch
    • Three significant publications, each with an annotation (100-word limit)
  • Identify the nomination’s supporter and send notification to the supporter to access her/his support form
  • Complete a demographics survey
  • Identify research domain(s)
  • Submit this aspect of the nomination, which can be done regardless of whether the nominator or supporter has completed her/his statement

The supporter:

  • Does not need to be an ASCI member
  • Must be identified and notified by the nominee
  • Provides a statement (500-word limit) of the nominee’s research contributions (the statement should be distinct from that of the nominator)

Take action for federal funding of research

Dear members of the ASCI community,

The ASCI has produced a campaign to highlight the critical importance of federal funding of scientific and medical research. “Fund Research / Save Our Cures” is available here:

https://fundresearch.org

Social: X / Twitter | Facebook | Bluesky | LinkedIn | Instagram | YouTube

The key campaign goals are to reach beyond our community to make the case for government investment in research and to prompt citizens to contact their Congressional representatives to support this investment.

Share the links freely and follow the campaign on the social platforms you use. If you haven’t already, take a moment to urge your representatives to support federal funding of science.

The campaign stems from internal and community conversations about the impact of the administration’s actions taken toward the NIH – well-known to us: the reduction of indirect costs earlier this year, the suspension or cancellation of grants already awarded, NIH campus workforce reductions and reorganization, and more recently the administration’s request to cut the NIH budget by an astounding 40%.

While the US House of Representatives agreed to the cut, the US Senate expressed its support for a stable NIH budget. At present it appears that the next US fiscal-year budget may not see a devastating reduction for the NIH or other agencies that support the scientific and biomedical enterprise. However, it takes only a quick read of the day’s headlines to see that America’s status as a scientific powerhouse is in the crosshairs.

To formulate our campaign, we undertook a survey of the general population to find out what people knew and which messages resonated with them. Among the findings, only 52% of respondents were aware that the government funds research. At a time when this research is producing amazing results and is poised to address significant challenges presented by major diseases, it’s unfortunate that awareness isn’t greater. However, it’s an opportunity for us, this campaign, and others like it: to engage with the tax-paying members of the public about the great work they’re supporting, to grow their understanding, and to have them join us in advocating to continue the progress research has made for many decades.

Priscilla Y. Hsue, MD
President, 2025-2026
The American Society for Clinical Investigation
https://the-asci.org
Social: X / Twitter | Bluesky

Nominations open for the 2026 ASCI / Stanley J. Korsmeyer Award

Nominations for the ASCI’s 2026 ASCI / Stanley J. Korsmeyer Award are now open.

This prestigious recognition, first called the ASCI Award, was renamed in 2006 in honor of Dr. Korsmeyer, the first recipient of the Award in 1998, who passed away in 2005. The Award recognizes individuals for their advancement of knowledge in a specific field and for mentoring future generations of life science researchers. Information on all past honorees is available here.

The Awardee delivers the Korsmeyer Award Lecture at the 2026 AAP/ASCI/APSA Joint Meeting, April 17-19, and receives an unrestricted $20,000 honorarium.

Current Active and International ASCI members are eligible for nomination. Prior nominees who remain eligible may be re-nominated. However, current ASCI Council members and prior Award recipients may not be nominated.

The deadline for receipt of nominations is October 15, 2025, at 11:59 pm Eastern. Nominations will be screened to ensure they are complete and fit the nomination criteria. The Council reviews nominations, with the outcome of review expected toward the end of November 2025.

Nominators:

  • may be any ASCI member in good standing, including members of the Council;
  • must provide a statement (250-word limit) regarding the nominee; and
  • must comment regarding other investigators who have significantly contributed to the discoveries related to the nomination.

Nominees:

  • must currently be an Active or International member (age 55 or younger);
  • must provide a biosketch, full curriculum vitae, and a trainee table;
  • must identify a former mentee to provide a statement of support (500-word limit);
  • must complete the ASCI’s demographic survey; and
  • must identify their research domain(s).

To start a nomination:

Nominations may be started by the nominator or the nominee:

  • Access your member account
  • Go to the “Activities / nominations” tab
  • Go to the section for “ASCI / Stanley J. Korsmeyer Award”

For the nominator:

  • Select “I’m the nominator” option
  • Search for your nominee
  • Click on “Start nomination”
  • If the nominee has not already claimed her/his part of the nomination, click on “Send nominee information to access the nominee’s part of the nomination” to send the nominee an email to access and edit her/his aspect of the nomination (see above).
  • Supply the required information (see above)
  • Submit this aspect of the nomination

For the nominee:

  • Select “I’m the nominee” option
  • Supply the required information (see above)
  • Submit this aspect of the nomination

Nominations open for the 2026 ASCI / Scharschmidt~Crawford Distinguished Lectureship and Award

Nominations for the ASCI’s 2026 Bruce F. Scharschmidt & Peggy S. Crawford Translational Medicine Distinguished Lectureship and Award are now open.

The Award recognizes those who have made important contributions to the development of high-impact diagnostics or therapeutics for patients. The Awardee delivers the Scharschmidt~Crawford Distinguished Lectureship at the annual AAP/ASCI/APSA Joint Meeting and receives an unrestricted $20,000 honorarium. Drs. Scharschmidt and Crawford have pledged a very generous philanthropic gift to the ASCI to fully endow the Award.

Any person with an MD or equivalent, regardless of ASCI membership, is eligible for nomination. However, current ASCI Council members may not be nominated.

The deadline for receipt of nominations is October 15, 2025, at 11:59 pm Eastern. Nominations will be screened to ensure they are complete and fit the nomination criteria. The Council reviews nominations, with the outcome of review expected in December 2025.

Nominators:

  • may be any ASCI member in good standing, including members of the Council, and
  • must provide a statement (250-word limit) regarding the nominee.

Nominees:

  • may be any person with an MD or equivalent, regardless of ASCI membership, but excluding members of the Council;
  • must be able to attend the 2026 Joint Meeting, April 17-19, in Chicago;
  • must provide a 500-word-limit description of their contributions to the development of high-impact diagnostics or therapeutics for patients;
  • must provide a full curriculum vitae;
  • must complete the ASCI’s demographic survey; and
  • must provide information regarding their research domain(s).

To start a nomination:

Nominations may be started by the nominator or the nominee:

  • Access your member account
  • Go to the “Activities / nominations” tab
  • Go to the section for “ASCI / Scharschmidt~Crawford Distinguished Lectureship and Award”

For the nominator:

  • Select “I’m the nominator” option
  • Search for your nominee
  • Click on “Start nomination”
  • If the nominee has not already claimed her/his part of the nomination, click on “Send nominee information to access the nominee’s part of the nomination” to send the nominee an email to access and edit her/his aspect of the nomination (see above).
  • Supply the required information (see above)
  • Submit this aspect of the nomination

For the nominee:

… if the nominee is an ASCI member:

  • Select “I’m the nominee” option
  • Supply the required information (see above)
  • Submit this aspect of the nomination

… if the nominee is not ASCI member, the nominee can email staff@the-asci.org to have a nomination set up by staff.

Nominations for Active and International membership, 2026

Nominations for Active and International membership for 2026 are open and may be submitted through the deadline of September 10, 2025, 11:59 pm Eastern. All participants in a nomination should carefully review the information below. Send questions to staff@the-asci.org.

Navigate to section:

About this cycle

Nominees for Active and International membership:

  • must be physicians who have “accomplished meritorious original, creative, and independent investigations in the clinical or allied sciences of medicine” and who enjoy “unimpeachable moral standing in the medical profession” (as stated in the ASCI bylaws);
  • may not be nominated more than three times; and
  • must be age 50 or younger on January 1, 2026.

Proposers are discouraged from nominating those whose qualifications may not be sufficiently advanced, or from re-nominating a candidate if the candidate’s work has changed little since their previous nominations.

The ASCI Council reviews nominations and may recommend up to 100 Active and International nominees for election. The Council presents the recommended nominee group to Active and Senior members to approve by vote. Those elected for 2026 will be recognized at the ASCI’s annual Dinner and New Member Induction Ceremony, April 17, 2026, as part of the 2026 AAP/ASCI/APSA Joint Meeting, April 17-19, at the Swissôtel Chicago.

Note that Council members may not serve in any capacity regarding nominations.

Nomination preparation guidance and instructions

A nomination requires one Proposer and one Seconder, both of whom must be ASCI members in good standing and (if applicable) current in Society dues. General Supporters are optional and are not required to be ASCI members. Note that Emeritus members may participate in any of these roles.

Note: A nominee may request that the nomination be set up for her/his editing by sending an email to staff@the-asci.org; if a Proposer has been identified, provide that person’s name in the request. 

There is no limit to the number of nominations a member can propose or support (either as Seconder or General Supporter).

The Proposer is ideally from an institution different from the nominee’s institution (although this is not required) and should have a good understanding of the nominee’s work. The Proposer is responsible for:

  • starting the nomination (see “ASCI account access” below);
  • granting access to the nominee to edit certain sections of the nomination (see detail in “Nomination sections” below); note that granting access is required, as demographic information can be supplied only by the nominee;
  • providing the “Proposer’s general statement on the nominee” (500-word limit) and “Statement on progress and development since previous nomination” (if applicable, 500-word limit);
  • ensuring that the nomination is accurate and complete; and
  • submitting the nomination.

Nominees can, when granted access, edit sections of the nomination except those exclusive to the Proposer. Only the nominee can provide demographic information, including research domain(s).

The Seconder is ideally from an institution different from the nominee’s institution (although this is not required) and should have a good understanding of the nominee’s work. The Seconder is responsible for completing and submitting a form that includes:

  • scores for the areas enumerated in the form;
  • comments (500-word limit) that supplement, but do not duplicate, information provided by the Proposer and deal specifically with the nominee’s original scientific contributions; and
  • a description of the relationship to the nominee.

General Supporters (not required; limited to 3 per nomination) may help to provide additional context for a nominee’s contributions, and to demonstrate wider support for the nominee beyond the candidate’s own institution, particularly if the Proposer and Seconder of a nomination are from the nominee’s institution. Anyone (including any ASCI member except those on the ASCI Council) may serve as a General Supporter. The General Supporter completes and submits a form that includes:

  • scores for the areas enumerated in the form;
  • comments (250-word limit) that supplement, but do not duplicate, information provided by the Proposer or the Seconder and deal specifically with the nominee’s original scientific contributions; and
  • description of the relationship to the nominee.

A nomination support template may be referenced in order to aid in drafting comments. Please note, however:

  • General Supporters who are ASCI members should complete and submit the required information online through their member accounts (see “ASCI account access”).
  • General Supporters who are not ASCI members should request that the Proposer add them to the nomination. The Proposer is then able to send an email containing information about accessing the support form on the ASCI website.

ASCI account access

  • Access your account
  • Go to the “Activities / nominations” tab, navigate to the “Active and International membership” section, and click on Search for a nominee.
  • Enter the nominee’s last name (you may enter a partial name):
    • If the nominee is found, you’ll be prompted to select your role if available: Proposer, Seconder, or General Supporter.
    • If the nominee isn’t found, provide the requested information to add the nominee and start the nomination by selecting your role (see bullet point immediately preceding).

Nomination sections

  • About the nominee
    Proposer and nominee may edit this information.
  • Nominee’s demographic information
    Only the nominee may edit this information.
    The ASCI requests responses to questions in a brief, 9-section survey that will help provide the foundation for expanding diversity, fostering inclusion, and achieving equity in the ASCI. All response areas are voluntary, with a “Prefer not to answer” option available for each section. Anyone with access to person-specific information (such as ASCI leadership, members associated with review processes, and staff members) will be required to keep the information confidential. Depersonalized summary information of all response areas may be provided in periodic public reports.
  • Nominee’s research domain(s)
    Only the nominee may edit this information.
  • Nominee’s institutional affiliation
    Proposer and nominee may edit this information.
  • Support for nomination
    — Only the Proposer has access to this section.
    Proposers may attach the Seconder and General Supporters to the nomination by searching the ASCI member directory. For a supporter who is not an ASCI member, Proposers must supply the supporter’s name and email address in order to attach the person to the nomination. After supporters are attached to the nomination, Proposers are provided the ability to notify them regarding their support forms.
  • Nominee’s biography
    Proposer and nominee may edit this information.
    Limited to 300 words, this brief summary of the nominee’s research and accomplishments will not be evaluated for review, but will be used to populate the nominee’s ASCI directory entry if the nominee is elected.
  • Documents
    Proposer and nominee may edit this information:

    • Full academic curriculum vitae, including:
      • current funding (clearly indicate whether the nominee is a principal investigator),
      • past funding,
      • invited lectures,
      • patents, and
      • full bibliography (with original research separated from other types of publications and the nominee’s name presented in bold face).
    • NIH-style biographical sketch (5-page limit), following the current format available at:
      http://grants.nih.gov/grants/forms/biosketch.htm
    • A high-resolution headshot photograph (for use if the nominee is recommended for election)
    • Three “Most significant publications,” excluding those representing work done by the nominee as a trainee. For each of these three files, an annotation is required and consists of three aspects:
      1. Citation: Author list in the original publication sequence, with the nominee’s name in capital letters, followed by numbered notation of the nominee’s role in parentheses (1 = principal investigator, 2 = collaborator), title, journal name, volume, inclusive page numbers, and year: Example:
        “John Q. Public and JANE DOE (1). Title. Journal. 1:1-10 (2015).”
      2. Pubmed ID (PMID).
      3. Annotation: A description (50-word limit) of the publication’s key findings and significance.
  • Seminal contribution(s)
    —  Proposer and nominee may edit this information.
    Summarize the nominee’s defining seminal contribution(s) and why this work forms the basis for the nomination (75-word limit). Use of lay terminology is encouraged.
  • Proposer’s general statement on the nominee
    Only the Proposer has access to this section.
    In the Proposer’s own words (500-word limit), describe the quality, originality, and impact of the nominee’s scientific work and the consistency and importance of the nominee’s research theme. Include a statement on the level of independence from the nominee’s mentor(s) and the nominee’s productivity and stature in the field.

    • Proposers should expand upon the candidate’s seminal contribution(s), including the originality, novelty, and impact of this research on the field. Note any special circumstances (e.g., childbearing or personal/family illness) that influenced the candidate’s research activities.
    • Information regarding major awards, invitations to give plenary lectures (especially at national and international meetings), and invitations to write chapters in major textbooks should be included as applicable — the quality and quantity of work are important factors.
  • Statement on progress and development since previous nomination
    Proposer and nominee may edit this information.
    In the Proposer’s own words (500-word limit), describe the critical differences between this nomination and the previous nomination (if applicable).

Recipient of the 2025 Louis W. Sullivan, MD, Award: Consuelo H. Wilkins, MD, MSCI

Consuelo H. Wilkins, MD, MSCI
Dr. Wilkins

The American Society for Clinical Investigation is pleased to recognize Consuelo H. Wilkins, MD, MSCI, as recipient of the 2025 ASCI/Louis W. Sullivan, MD, Award, for her groundbreaking contributions in community engagement and health equity, including large-cohort imaging studies suggesting that amyloid-directed therapies are less likely to benefit Black, Hispanic, and Asian individuals with memory loss. Dr. Wilkins receives an honorarium of $10,000 and delivers a scientific talk at the 2026 AAP/ASCI/APSA Joint Meeting.

As part of her work in Alzheimer’s disease, Dr. Wilkins used amyloid PET imaging on large cohorts of individuals with memory loss and found that the odds of having a positive scan were lower among Black, Latino, and Asian populations. The results indicate that fewer people in these groups will be eligible for recently approved anti-amyloid therapies compared with White individuals.

Dr. Wilkins’ research has transformed efforts to increase clinical research engagement and improve health outcomes for all. Her team established the Community Engagement Studio (CES), a formalized approach to incorporating the voice of community stakeholders at all stages of clinical research — a model adopted by numerous studies and many academic health centers in the US, Canada, and the United Kingdom. Dr. Wilkins has developed and validated instruments to measure trust in research and standards for compensating community partners. She has created frameworks that serve as a blueprint for academic medical centers to personalize care based on the needs of their populations.

Dr. Sullivan’s transformational work has been an inspiration for me. My work spans clinical research, policy-focused systems change, and advocacy for health equity – all of which are areas where Dr. Sullivan is an icon. In my current roles, I have the unique opportunity to leverage my research to build new programs and develop institutional policies that ensure everyone has an opportunity to achieve optimal health.

– Dr. Wilkins

Dr. Jeffrey R. Balser, President and CEO, Vanderbilt University Medical Center (VUMC) and Dean, Vanderbilt University School of Medicine, nominated Dr. Wilkins for this recognition. He wrote, “Dr. Wilkins embodies the spirit of the Award through her groundbreaking work. Her research, particularly in Alzheimer’s disease, has reshaped the field. She leads initiatives that measurably enhance participation from all communities and promote institutional change.”

Dr. Wilkins received her MD from Howard University College of Medicine, completed a residency at Duke University Medical Center and fellowship in geriatric medicine at Barnes-Jewish Hospital/Washington University School of Medicine; and received her MSCI from Washington University School of Medicine. She is currently Senior Vice President and Senior Associate Dean for Community Health and Engagement, Mildred Thornton Stahlman Chair in Rural Health, and Professor of Medicine, VUMC; and Associate Director, Vanderbilt Institute for Clinical and Translational Research. She was elected to the National Academy of Medicine in 2020 and to the ASCI in 2022.